H. Qian

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects

Jingshan Shen, Zhen Wang, Guanghui Tian, 2021, Drug design, development and therapy.

Effects of a High-fat Meal on the Pharmacokinetics of the VEGFR Inhibitor Fruquintinib: A Randomized Phase I Study in Healthy Subjects.

S. Fan, Qian Chen, Y. Sai, 2019, Clinical therapeutics.

A phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX04 to reference bevacizumab sourced from the United States, the European Union, and China in healthy Chinese male volunteers

Xiaojiao Li, Yanhua Ding, Min Wu, 2021, Cancer Chemotherapy and Pharmacology.

Liquid chromatography-tandem mass spectrometric assay for TPN171 in human plasma.

Jingshan Shen, Zhen Wang, Gang-yi Liu, 2020, Journal of pharmaceutical and biomedical analysis.

Pharmacokinetics, safety, and tolerability of sulcardine sulfate: an open‐label, single‐dose, randomized study in healthy Chinese subjects

Dong Lu, Qian Chen, Chaoying Hu, 2017, Fundamental & clinical pharmacology.

Safety, tolerability, and pharmacokinetics of VV116, an oral nucleoside analog against SARS-CoV-2, in Chinese healthy subjects

Huahua Duan, Wenhong Zhang, H. Aisa, 2022, Acta Pharmacologica Sinica.

Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor: A phase I study in healthy young and elderly Chinese subjects

Hong Liu, Haiyan Zhang, Xiaoyan Chen, 2023, Clinical and translational science.

Effects of Food on the Pharmacokinetic Properties of Surufatinib: A Phase I, Single-dose, Randomized, Open-label Crossover Study in Healthy Subjects.

Qian Chen, Y. Sai, W. Su, 2020, Clinical therapeutics.